business

Cantor Fitzgerald reiterates Eledon Pharmaceuticals stock rating on kidney transplant data

Investing.com · Jun 22, 2026, 12:22 PM · Also reported by 3 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Cantor Fitzgerald Lifts PT on Lam Research Corporation (LRCX) STAT News STAT+: Despite transplant referrals, most kidney patients don’t make the waitlist Yahoo Finance SpaceX stock falls after MSCI gives lowest ESG rating

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Cantor Fitzgerald reiterates Eledon Pharmaceuticals stock rating on kidney transplant data

Also covered by

More in business